Does Probe's Eye Subthalamic Nucleus Length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?

Creative Commons License

Kocabıçak E., AYGÜN D., Ozaydin I., Jahanshahi A., Tan S. K. H., Onar M., ...More

TURKISH NEUROSURGERY, vol.23, no.5, pp.658-665, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 5
  • Publication Date: 2013
  • Doi Number: 10.5137/1019-5149.jtn.8328-13.0
  • Journal Name: TURKISH NEUROSURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.658-665
  • Keywords: Parkinson's disease, Subthalamic nucleus, Microelectrode recording, Magnetic resonance imaging, Deep brain stimulation, SAFETY, RISK
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

AIM: Subthalamic nucleus (STN) deep brain stimulation (DBS) has become a well-accepted treatment for patients with advanced Parkinson's disease (PD). During surgical planning for DBS, the length of the STN is taken into account and verified during microelectrode recording (MER) intraoperatively. Here, we addressed the question to which extent the length of the STN measured with the 12 weighted MRI in the probe's eye view corresponded with the intraoperatively determined length of the STN with MER.